Lexicon Pharmaceuticals I... (LXRX)
NASDAQ: LXRX
· Real-Time Price · USD
1.24
0.06 (5.08%)
At close: Aug 15, 2025, 3:59 PM
1.23
-0.40%
After-hours: Aug 15, 2025, 07:58 PM EDT
Lexicon Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -120.62M | -177.3M | -200.4M | -214.88M | -200.59M | -192.07M | -175.61M | -157.86M | -130.72M | -110.4M | -101.94M | -97.06M | -96.8M | -90.28M | -87.76M | -67.64M | 38.08M | -12.92M |
Depreciation & Amortization | 603K | 566K | 534K | 556K | 581K | 586K | 554K | 510K | 467K | 430K | 427K | 436K | 429K | 364K | 292K | 524K | 1.21M | 2.06M |
Stock-Based Compensation | 10.58M | 12.24M | 13.5M | 15.17M | 16.27M | 15.23M | 14.34M | 14.4M | 13.15M | 12.16M | 11.52M | 10.48M | 10.54M | 10.5M | 10.58M | 11.03M | 10.22M | 11.69M |
Other Working Capital | 2.89M | 2.39M | -720K | -4.42M | -1.56M | -3.68M | 1.04M | 2.41M | 1.04M | 2.86M | 340K | 245K | 89.83M | 181.07M | 287.01M | 286.73M | 195.21M | 103.61M |
Other Non-Cash Items | 7.79M | -6.93M | -4.18M | 2.49M | -1.55M | 3.08M | 3.05M | -2.11M | 1.1M | 984K | 744K | 404K | 204K | 65K | 54K | -132.52M | -132.27M | -131.92M |
Deferred Income Tax | n/a | n/a | n/a | -6.9M | -6.9M | -6.9M | -6.9M | n/a | n/a | n/a | n/a | 49K | 49K | 49K | 49K | 130.85M | -1.71M | -110K |
Change in Working Capital | -249K | 4M | 11.77M | -4.28M | -3.65M | -5.34M | 2.66M | 12.14M | 5.26M | -218K | 402K | -4.42M | -2.25M | -5.98M | -10.23M | -40.67M | -37.19M | -14.88M |
Operating Cash Flow | -101.89M | -167.43M | -178.78M | -207.84M | -195.84M | -185.41M | -161.9M | -132.92M | -110.74M | -97.04M | -88.85M | -90.11M | -87.82M | -85.28M | -87.02M | -98.43M | -121.66M | -146.07M |
Capital Expenditures | -781K | -1.03M | -1.03M | -557K | -333K | -222K | -470K | -1.72M | -1.64M | -1.5M | -1.33M | -103K | -312K | -1.26M | -1.22M | -1.25M | -1.07M | -125K |
Cash Acquisitions | n/a | n/a | n/a | -101.37M | -62.13M | 12.34M | n/a | 75.95M | 113.9M | 39.43M | 51.77M | 77.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -169.35M | -219.24M | -336.17M | -310.44M | -332.64M | -377.7M | -223.34M | -223.83M | -244.78M | -145M | -133.95M | -138.74M | -50.06M | -30.39M | -34.26M | -34.24M | -45.78M | -47.02M |
Sales Maturities Of Investments | 323.41M | 346.95M | 314.4M | 286.4M | 223M | 205.66M | 173.87M | 147.88M | 130.88M | 91.92M | 64.2M | 49.69M | 38.01M | 47.08M | 37.59M | 64.59M | 131.77M | 196M |
Other Investing Acitivies | 9.96M | 8.74M | -102.81M | -50.91M | -97.57M | -172.04M | -49.47M | -75.95M | -113.9M | -53.08M | -69.75M | -89.05M | -12.05M | 16.68M | 3.33M | 8.22M | 168.8M | 231.79M |
Investing Cash Flow | 163.23M | 135.43M | -15.38M | -17.18M | -109.97M | -172.26M | -49.94M | -77.67M | -115.54M | -54.58M | -71.08M | -89.16M | -12.36M | 15.43M | 2.11M | 40.12M | 256.32M | 320.25M |
Debt Repayment | n/a | n/a | n/a | -1K | n/a | 49.96M | 49.96M | 74.93M | 74.68M | 24.72M | 48.87M | 23.9M | 24.15M | 24.15M | n/a | -5.82M | -215.94M | -216.26M |
Common Stock Repurchased | n/a | n/a | -1.73M | -1.52M | -1.52M | -1.52M | -613K | -824K | -824K | -824K | -864K | -864K | -864K | -864K | -2.67M | -2.67M | -2.67M | -2.78M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -46.42M | -1.44M | -1.27M | -1.33M | -414K | 138.63M | 139.03M | 139.03M | 233.3M | 87.95M | 87.95M | 76.25M | -18.02M | -11.7M | -11.7M | n/a | n/a | n/a |
Financial Cash Flow | -46.59M | -1.61M | 238.35M | 238.45M | 239.16M | 428.17M | 187.96M | 212.87M | 307.1M | 118.1M | 142.21M | 105.98M | 31.74M | 31.72M | 22.71M | 98.18M | -131.72M | -132.12M |
Net Cash Flow | 14.75M | -33.61M | 44.19M | 13.44M | -66.65M | 70.49M | -23.88M | 2.28M | 80.82M | -33.52M | -17.72M | -73.28M | -68.44M | -38.13M | -62.2M | 39.87M | 2.94M | 42.06M |
Free Cash Flow | -102.68M | -168.46M | -179.81M | -208.39M | -196.17M | -185.64M | -162.37M | -134.63M | -112.38M | -98.54M | -90.18M | -90.21M | -88.13M | -86.54M | -88.24M | -99.68M | -122.73M | -146.2M |